149 related articles for article (PubMed ID: 31481418)
21. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
Li X; Li M
Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
[TBL] [Abstract][Full Text] [Related]
22. Patient-Derived Xenograft Models for Ovarian Cancer.
Tran TM; Ho GY; Chu S
Methods Mol Biol; 2024; 2806():187-196. PubMed ID: 38676803
[TBL] [Abstract][Full Text] [Related]
23. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
24. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
25. Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models.
Jeon S; Jun E; Chang H; Yhee JY; Koh EY; Kim Y; Jung JY; Jeong EJ; Lee JW; Shim MK; Yoon HY; Chang S; Kim K; Kim SC
J Control Release; 2022 Nov; 351():37-49. PubMed ID: 36089170
[TBL] [Abstract][Full Text] [Related]
26. Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.
Chang SH; Ice RJ; Chen M; Sidorov M; Woo RWL; Rodriguez-Brotons A; Jian D; Kim HK; Kim A; Stone DE; Nazarian A; Oh A; Tranah GJ; Nosrati M; de Semir D; Dar AA; Desprez PY; Kashani-Sabet M; Soroceanu L; McAllister SD
Mol Cancer Ther; 2023 Sep; 22(9):1100-1111. PubMed ID: 37440705
[TBL] [Abstract][Full Text] [Related]
27. A new method of cryopreserving colorectal carcinoma cells for patient derived xenograft model generation.
Hu Y; Mi Y; Mukherjee P; Pan Y
Cryobiology; 2020 Oct; 96():45-49. PubMed ID: 32861699
[TBL] [Abstract][Full Text] [Related]
28. Generation and application of patient-derived xenograft models in pancreatic cancer research.
Wang CF; Shi XJ
Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
[TBL] [Abstract][Full Text] [Related]
29. Patient-Derived Xenografts of Breast Cancer.
Varešlija D; Cocchiglia S; Byrne C; Young L
Methods Mol Biol; 2017; 1501():327-336. PubMed ID: 27796962
[TBL] [Abstract][Full Text] [Related]
30. Generation of stable PDX derived cell lines using conditional reprogramming.
Borodovsky A; McQuiston TJ; Stetson D; Ahmed A; Whitston D; Zhang J; Grondine M; Lawson D; Challberg SS; Zinda M; Pollok BA; Dougherty BA; D'Cruz CM
Mol Cancer; 2017 Dec; 16(1):177. PubMed ID: 29212548
[TBL] [Abstract][Full Text] [Related]
31. Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.
Verma B; Ritchie M; Mancini M
Curr Protoc Pharmacol; 2017 Sep; 78():14.41.1-14.41.12. PubMed ID: 28892144
[TBL] [Abstract][Full Text] [Related]
32. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in patient-derived xenografts of odontogenic myxoma.
Souza JC; Bastos VC; Pereira NB; Dias AAM; Avelar GF; Gomez RS; Gomes CC
Int J Exp Pathol; 2022 Apr; 103(2):65-69. PubMed ID: 35225401
[TBL] [Abstract][Full Text] [Related]
34. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.
Koga Y; Ochiai A
Cells; 2019 May; 8(5):. PubMed ID: 31064068
[TBL] [Abstract][Full Text] [Related]
35. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived xenograft models-the future of personalised cancer treatment.
Bhimani J; Ball K; Stebbing J
Br J Cancer; 2020 Mar; 122(5):601-602. PubMed ID: 31919403
[TBL] [Abstract][Full Text] [Related]
37. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
[TBL] [Abstract][Full Text] [Related]
38. PDXliver: a database of liver cancer patient derived xenograft mouse models.
He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
[TBL] [Abstract][Full Text] [Related]
39. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
40. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
Wang Y; Cui J; Wang L
Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
